DiaSorin Past Earnings Performance
Past criteria checks 3/6
DiaSorin's earnings have been declining at an average annual rate of -3.2%, while the Medical Equipment industry saw earnings growing at 3.9% annually. Revenues have been growing at an average rate of 10.8% per year. DiaSorin's return on equity is 11.6%, and it has net margins of 16%.
Key information
-3.2%
Earnings growth rate
-4.9%
EPS growth rate
| Medical Equipment Industry Growth | -9.5% |
| Revenue growth rate | 10.8% |
| Return on equity | 11.6% |
| Net Margin | 16.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How DiaSorin makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,178 | 189 | 418 | 88 |
| 30 Jun 24 | 1,161 | 168 | 416 | 88 |
| 31 Mar 24 | 1,147 | 164 | 414 | 90 |
| 31 Dec 23 | 1,148 | 160 | 414 | 91 |
| 30 Sep 23 | 1,195 | 150 | 414 | 93 |
| 30 Jun 23 | 1,252 | 188 | 420 | 97 |
| 31 Mar 23 | 1,293 | 200 | 420 | 98 |
| 31 Dec 22 | 1,361 | 241 | 415 | 97 |
| 30 Sep 22 | 1,391 | 285 | 410 | 97 |
| 30 Jun 22 | 1,408 | 302 | 391 | 93 |
| 31 Mar 22 | 1,329 | 315 | 346 | 80 |
| 31 Dec 21 | 1,238 | 311 | 305 | 70 |
| 30 Sep 21 | 1,130 | 315 | 258 | 57 |
| 30 Jun 21 | 1,014 | 303 | 223 | 49 |
| 31 Mar 21 | 973 | 288 | 219 | 51 |
| 31 Dec 20 | 881 | 248 | 217 | 51 |
| 30 Sep 20 | 791 | 212 | 213 | 52 |
| 30 Jun 20 | 738 | 186 | 214 | 50 |
| 31 Mar 20 | 710 | 173 | 214 | 49 |
| 31 Dec 19 | 706 | 176 | 213 | 48 |
| 30 Sep 19 | 700 | 168 | 212 | 46 |
| 30 Jun 19 | 688 | 161 | 209 | 46 |
| 31 Mar 19 | 675 | 160 | 206 | 45 |
| 31 Dec 18 | 669 | 158 | 201 | 45 |
| 30 Sep 18 | 663 | 161 | 197 | 45 |
| 30 Jun 18 | 649 | 154 | 192 | 44 |
| 31 Mar 18 | 644 | 145 | 189 | 45 |
| 31 Dec 17 | 637 | 140 | 188 | 44 |
| 30 Sep 17 | 625 | 125 | 185 | 43 |
| 30 Jun 17 | 622 | 125 | 183 | 43 |
| 31 Mar 17 | 602 | 121 | 178 | 41 |
| 31 Dec 16 | 569 | 112 | 170 | 38 |
| 30 Sep 16 | 544 | 111 | 164 | 34 |
| 30 Jun 16 | 520 | 106 | 158 | 30 |
| 31 Mar 16 | 506 | 102 | 155 | 27 |
| 31 Dec 15 | 499 | 100 | 154 | 26 |
| 30 Sep 15 | 486 | 95 | 151 | 25 |
| 30 Jun 15 | 472 | 93 | 148 | 25 |
| 31 Mar 15 | 455 | 87 | 144 | 25 |
| 31 Dec 14 | 444 | 84 | 140 | 25 |
| 30 Sep 14 | 437 | 84 | 139 | 25 |
| 30 Jun 14 | 432 | 82 | 137 | 24 |
| 31 Mar 14 | 435 | 82 | 137 | 24 |
| 31 Dec 13 | 435 | 83 | 136 | 24 |
Quality Earnings: DIAM has high quality earnings.
Growing Profit Margin: DIAM's current net profit margins (16%) are higher than last year (12.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DIAM's earnings have declined by 3.2% per year over the past 5 years.
Accelerating Growth: DIAM's earnings growth over the past year (26%) exceeds its 5-year average (-3.2% per year).
Earnings vs Industry: DIAM earnings growth over the past year (26%) did not outperform the Medical Equipment industry 39.9%.
Return on Equity
High ROE: DIAM's Return on Equity (11.6%) is considered low.